[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":7457000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-190000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-10000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":-13878000.0,"DeferredRevenueCurrent_0_Q3_USD":24950000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":5164000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-27260000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":25757000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":39044000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":818000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":30533847.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":30368437.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":8.64,"DeferredRentCreditNoncurrent_0_Q3_USD":120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":72902000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":141315.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":8.34,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1078963.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":20503000.0,"OtherAssetsNoncurrent_0_Q3_USD":86000.0,"EarningsPerShareBasic_1_Q3_USD":0.18,"EarningsPerShareBasic_3_Q3_USD":-0.9,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":15000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":15.72,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":11.78,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4685276.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2015685.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":231000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1186000.0,"EarningsPerShareDiluted_1_Q3_USD":0.17,"ProceedsFromStockPlans_3_Q3_USD":1112000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":95049000.0,"PaymentsOfStockIssuanceCosts_1_Q3_USD":600000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":275000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-55000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"DeferredRevenueNoncurrent_0_Q3_USD":55576000.0,"DeferredRentCreditCurrent_0_Q3_USD":151000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":-0.9,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q3_USD":-190000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-3479000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":115066000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-429000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":231000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":1524000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3651000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q3_USD":2996000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2996000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":8029000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":115000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":98355000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-190000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_3_Q3_USD":-10000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1524000.0,"AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":7457000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":32366141.0,"LiabilitiesCurrent_0_Q3_USD":35578000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":221578000.0,"Liabilities_0_Q3_USD":91274000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":530000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1832000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1893000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-427000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-115000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-27677000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":5239000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13368000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4751000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":8617000.0,"CostsAndExpenses_3_Q3_USD":68245000.0,"CommonStockValue_0_Q3_USD":3000.0,"CommonStockSharesOutstanding_0_Q3_shares":30827653.0,"CommonStockSharesIssued_0_Q3_shares":30827653.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":98080000.0,"AssetsCurrent_0_Q3_USD":218401000.0,"Assets_0_Q3_USD":221578000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4918732.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":553502.0,"AdditionalPaidInCapital_0_Q3_USD":255030000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":34000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1635000.0,"AccountsPayableCurrent_0_Q3_USD":3020000.0,"CostsAndExpenses_1_Q3_USD":20749000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":19476000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-31572000.0,"NetIncomeLoss_1_Q3_USD":5354000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30368437.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":477000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":176497.0,"ShareBasedCompensation_3_Q3_USD":8029000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15998000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":54877000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_1_Q3_USD":5008000.0,"OperatingIncomeLoss_3_Q3_USD":-29201000.0,"IncomeTaxesPaidNet_3_Q3_USD":480000.0,"DepreciationAndAmortization_3_Q3_USD":852000.0,"CommonStockSharesAuthorized_0_Q3_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q3_USD":960000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":30533847.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":30368437.0,"StockholdersEquity_0_Q3_USD":130304000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-124763000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2816000.0,"ProfitLoss_3_Q3_USD":-27250000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3620000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":475000.0,"NetIncomeLoss_3_Q3_USD":-27250000.0,"RestrictedCash_0_Q3_USD":275000.0,"StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_1_Q3_USD":431000.0,"Ticker":"MORF","CIK":"1679363","name":"MORPHIC HOLDING, INC.","OfficialName":"Morphic Holding Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1330068663.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]